MADRIGAL PHARMACEUTICALS, INC. 4

Richard S. Levy sold 5,642 shares of Madrigal Pharmaceuticals, Inc. common stock on May 22, 2026 under a Rule 10b5‑1 plan for approximately $2.9 million in total proceeds.

On May 22, 2026, Richard S. Levy of Madrigal Pharmaceuticals, Inc. executed a series of open‑market sales of Madrigal common stock pursuant to a pre‑arranged Rule 10b5‑1 trading plan adopted on February 20, 2026. Across eleven transactions that day, he sold a total of 5,642 shares at weighted‑average prices ranging from approximately $506.68 to $519.98 per share, for aggregate proceeds of roughly $2.89 million. Following these planned sales, his direct beneficial ownership decreased to 22,015 shares of Madrigal common stock, representing an estimated remaining stake of about $11.4 million based on the reported sale prices.

Filing Facts

CIK

1157601

Ticker

MDGL

Form

4

Source Type

sec

Accession

0001628280-26-037830

Alert Tier

7